Thromboxane formation during blood clotting is decreased by verapamil.
D001777:Blood Coagulation / Q000187:drug effects*; D001792:Blood Platelets / Q000187:drug effects*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D008689:Methacrylates / Q000494:pharmacology; D013442:Sulfinpyrazone / Q000494:pharmacology; D013929:Thromboxane B2 / Q000096:biosynthesis*; D013931:Thromboxanes / Q000096:biosynthesis*; D014700:Verapamil / Q000494:pharmacology*
D008689:Methacrylates; D013931:Thromboxanes; D013929:Thromboxane B2; C031517:2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid; D014700:Verapamil; D013442:Sulfinpyrazone; D007213:Indomethacin